137 related articles for article (PubMed ID: 27986886)
1. RE: Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Bujko K; Rutkowski A
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27986886
[No Abstract] [Full Text] [Related]
2. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
[TBL] [Abstract][Full Text] [Related]
3. The role of chemoradiotherapy in organ preservation for rectal cancer.
Xie L; Chen Q; Zhu J
Ann Oncol; 2023 Apr; 34(4):440. PubMed ID: 36549588
[No Abstract] [Full Text] [Related]
4. Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy".
Kanemoto Y; Kurokawa T; Tanimoto T
Ann Surg; 2019 Dec; 270(6):e118-e119. PubMed ID: 31425284
[No Abstract] [Full Text] [Related]
5. Is organ preservation in rectal cancer ready for prime time?
Tekkis P; Tait D; Cunningham D; Brown G
Lancet; 2018 Jun; 391(10139):2480-2482. PubMed ID: 29976455
[No Abstract] [Full Text] [Related]
6. 2023 A new French revolution: Organ preservation for rectal cancer.
Gérard JP
Cancer Radiother; 2024 Apr; 28(2):143-144. PubMed ID: 38508953
[No Abstract] [Full Text] [Related]
7. Contact Radiation Therapy for Achieving Organ Preservation in Rectal Cancer After Standard Neoadjuvant Chemoradiation: Looking for a Place in the Sun.
Habr-Gama A; Perez RO
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):574-576. PubMed ID: 29413272
[No Abstract] [Full Text] [Related]
8. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
9. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
[TBL] [Abstract][Full Text] [Related]
10. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Martens MH; Maas M; Heijnen LA; Lambregts DM; Leijtens JW; Stassen LP; Breukink SO; Hoff C; Belgers EJ; Melenhorst J; Jansen R; Buijsen J; Hoofwijk TG; Beets-Tan RG; Beets GL
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27509881
[TBL] [Abstract][Full Text] [Related]
11. Response to Comment on "Organ Preservation for cT2N0 Distal Rectal Cancer-Are There Any Better Surgical Alternatives Without Chemoradiation?".
Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; Araújo SEA; Sabbaga J; Aguilar PB; Perez RO
Ann Surg; 2019 Dec; 270(6):e119-e120. PubMed ID: 31045873
[No Abstract] [Full Text] [Related]
12. [Organ preservation in patients with rectal cancer after total neoadjuvant treatment].
Germer CT; Reibetanz J
Chirurgie (Heidelb); 2022 Oct; 93(10):997-998. PubMed ID: 36053321
[No Abstract] [Full Text] [Related]
13. Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial.
Gérard JP; Chamorey E; Gourgou-Bourgade S; Benezery K; de Laroche G; Mahé MA; Boige V; Juzyna B
Radiother Oncol; 2015 May; 115(2):246-52. PubMed ID: 25921382
[TBL] [Abstract][Full Text] [Related]
14. [Choice of neoadjuvant therapy for rectal cancer: simple chemotherapy or synchronous chemoradiotherapy].
Li J; Deng Y; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):627-631. PubMed ID: 29968236
[TBL] [Abstract][Full Text] [Related]
15. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
16. [Research progress on pathologic complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer].
Peng HH; You KY; Gao YH; Wen BX
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):592-6. PubMed ID: 23801217
[TBL] [Abstract][Full Text] [Related]
17. Radio- or Chemotherapy Dose Escalation for Organ Preservation in Rectal Cancer?
Socha J; Żółciak-Siwińska A; Bujko K
J Clin Oncol; 2023 Jan; 41(2):417. PubMed ID: 36126242
[No Abstract] [Full Text] [Related]
18. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
[TBL] [Abstract][Full Text] [Related]
19. New hope from OPERA trial for surgically fit rectal cancer patients who wish to have organ preservation.
Myint AS
Colorectal Dis; 2022 Sep; 24(9):1026-1027. PubMed ID: 36178736
[No Abstract] [Full Text] [Related]
20. MRI Linac and How It May Potentially Lead to More Complete Response in Rectal Cancer.
Chand M; Oliva Perez R
Dis Colon Rectum; 2018 Jun; 61(6):643-644. PubMed ID: 29722720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
